Jean-Jacques Garaud - Executive Vice-President, Scientific and Medical Affairs - Inotrem | LinkedIn
Leadership Team - Inotrem
Jean-Jacques Garaud email address & phone number | Inotrem Executive Vice-President, Scientific and Medical Affairs contact information - RocketReach
Inotrem closes $43M series B round for phase IIb trial of nangibotide in septic shock | 2019-09-12 | BioWorld
Andera Partners s'entretient avec Jean-Jacques Garaud, CEO d'INOTREM, au portefeuille de notre équipe Andera Life Sciences on Vimeo
138 Marie France Garaud Photos and Premium High Res Pictures - Getty Images
Inotrem lève 39 millions d'euros pour combattre le choc septique | Les Echos
Roche | Jean-Jacques Garaud
COMPANY | Inotrem
Jean-Jacques Garaud - Co-Founder, Executive Vice-President, Scientific and Medical Affairs @ Inotrem - Crunchbase Person Profile
Inotrem announces €39 Million Series B Financing to Develop First- In-Class Immunology Therapeutics
Jean-Jacques Garaud | Nature Reviews Drug Discovery
5 September 2011
Jean-Jacques Garaud - Executive Vice-President, Scientific and Medical Affairs - Inotrem | LinkedIn
Leadership Team - Inotrem
Jean-Jacques Garaud - Executive Vice-President, Scientific and Medical Affairs - Inotrem | LinkedIn
Jean-Jacques Garaud - Co-Founder, Executive Vice-President, Scientific and Medical Affairs @ Inotrem - Crunchbase Person Profile
Zimmermann replaces ex-Roche pRED chief as Inotrem CEO | Fierce Biotech
Jean-Jacques Garaud - Executive Vice-President, Scientific and Medical Affairs - Inotrem | LinkedIn
Jean-Jacques Garaud - Co-Founder, Executive Vice-President, Scientific and Medical Affairs @ Inotrem - Crunchbase Person Profile
Founders – ENYO Pharma
PDF) sTREM-1 is a specific biomarker of TREM-1 pathway activation
112 Marie France Garaud Photos and Premium High Res Pictures - Getty Images
Amazon.com: Jacques Calvet: books, biography, latest update
Inotrem sparks hope with new phase 2b data
